Neurogene (NGNE) Other Non Operating Income (2013 - 2026)
Neurogene (NGNE) posted Other Non Operating Income of $163000.0 for Q1 2026, up 4.49% on a QoQ basis from $156000.0 in Q4 2025, and up 10.14% year-over-year from $148000.0 in Q1 2025.
Neurogene (NGNE) Other Non Operating Income (2013 - 2026) Analysis & Trends
Neurogene's Other Non Operating Income history runs 12 years deep, the most recent figure standing at $163000.0 for Q1 2026.
- Quarterly Other Non Operating Income rose 10.14% year-over-year to $163000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (up 190.16% YoY) and the FY2025 annual result came in at $1.7 million, up 190.07% from the prior year.
- Other Non Operating Income was $163000.0 for Q1 2026 at Neurogene, up from $156000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $16.4 million in Q4 2023 and bottomed at $143000.0 in Q1 2024.
- A 4-year average of $1.9 million and a median of $148500.0 in 2025 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2024 — Other Non Operating Income slumped 99.12% — and 2025, when it surged 741.67%.
- Neurogene's Other Non Operating Income stood at $16.4 million in 2023, then slumped by 99.12% to $144000.0 in 2024, then increased by 8.33% to $156000.0 in 2025, then climbed by 4.49% to $163000.0 in 2026.
- Business Quant data shows NGNE's Other Non Operating Income at $163000.0 in Q1 2026, $156000.0 in Q4 2025, and $149000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - |
| 10 | Neurogene | 797.65 Mn | 797.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 163,000.00 |
| Dec 31, 2025 | 156,000.00 |
| Sep 30, 2025 | 149,000.00 |
| Jun 30, 2025 | 1.21 Mn |
| Mar 31, 2025 | 148,000.00 |
| Dec 31, 2024 | 144,000.00 |
| Sep 30, 2024 | 143,000.00 |
| Jun 30, 2024 | 144,000.00 |
| Mar 31, 2024 | 143,000.00 |
| Dec 31, 2023 | 16.36 Mn |
| Mar 31, 2020 | 15,000.00 |
| Mar 31, 2019 | 2,000.00 |
| Dec 31, 2018 | 1.08 Mn |
| Sep 30, 2018 | -3,000.00 |
| Jun 30, 2018 | -118,000.00 |
| Mar 31, 2018 | -1,000.00 |
| Dec 31, 2017 | 976,000.00 |
| Sep 30, 2017 | 8,000.00 |
| Jun 30, 2017 | -12,000.00 |
| Mar 31, 2017 | -8,000.00 |